With 0.11 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.12 million shares. During the session, the Information Technology Services company that operates in wider Technology sector, reached to the highest price of $21.6 whereas the lowest price it dropped to was $20.87. The 52-week range on IBEX shows that it touched its highest point at $22.43 and its lowest point at $13.00 during that stretch. It currently has a 1-year price target of $23.00. Beta for the stock currently stands at 0.78.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of IBEX was up-trending over the past week, with a rise of 0.05%, but this was up by 8.64% over a month. Three-month performance surged to 10.65% while six-month performance rose 35.05%. The stock gained 22.23% in the past year, while it has gained 0.05% so far this year. A look at the trailing 12-month EPS for IBEX yields 1.89 with Next year EPS estimates of 2.66. For the next quarter, that number is 0.51. This implies an EPS growth rate of 14.76% for this year and 10.37% for next year.
Float and Shares Shorts:
At present, 16.77 million IBEX shares are outstanding with a float of 13.11 million shares on hand for trading. On 2024-12-13, short shares totaled 0.16 million, which was 119.00000000000001 higher than short shares on 1731628800. In addition to Mr. Robert T. Dechant as the firm’s CEO & Director, Mr. Taylor C. Greenwald serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.5839 of IBEX’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, IBEX reported revenue of $129717000.0 and operating income of $9092000.0. The EBITDA in the recently reported quarter was $14044000.0 and diluted EPS was $0.43.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for IBEX since 3 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With IBEX analysts setting a high price target of 25.0 and a low target of 21.0, the average target price over the next 12 months is 23.0. Based on these targets, IBEX could surge 16.28% to reach the target high and fall by -2.33% to reach the target low. Reaching the average price target will result in a growth of 6.98% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $2.05309 being high and $2.04691 being low. For IBEX, this leads to a yearly average estimate of $2.05.
